The world of chemistry is built upon a foundation of understanding molecular structures and their potential transformations. 5,6,7,8-Tetrahydroquinazolin-4-ol, a significant heterocyclic compound identified by CAS number 19178-19-9, exemplifies the importance of versatile intermediates in chemical synthesis. Typically presented as a white to off-white solid powder with high purity (over 98%), this molecule is a cornerstone for researchers and developers in various scientific fields.

The quinazoline ring system, partially saturated in this particular derivative, offers unique reactivity that makes 5,6,7,8-Tetrahydroquinazolin-4-ol an attractive building block. Its structure allows for a range of chemical modifications, including potential derivatization at the hydroxyl group or modifications to the saturated ring. This adaptability is precisely why many seek to buy 5,6,7,8-Tetrahydroquinazolin-4-ol for applications ranging from medicinal chemistry to materials science. For those actively looking for a high purity tetrahydroquinazolinone supplier, identifying a manufacturer that can consistently deliver this quality is paramount.

As a leading manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. specializes in producing such critical intermediates. We understand the nuanced requirements of our B2B clients who rely on us to source essential chemicals. By providing 5,6,7,8-Tetrahydroquinazolin-4-ol at competitive prices, we aim to facilitate research and development projects, making it easier for scientists to access the materials they need. Our role as a trusted supplier extends beyond mere product delivery; we are partners in innovation.

For organizations involved in drug discovery, finding a reliable chemical building block for drug discovery is a continuous effort. 5,6,7,8-Tetrahydroquinazolin-4-ol is a prime example of such a compound. Its chemical versatility, coupled with the assurance of purity and consistent supply from a reputable pharmaceutical intermediate 19178-199 provider, empowers scientists to push the boundaries of chemical synthesis and therapeutic development.